Addition of Nonauthor Collaborators and a Supplement

No authors listed

Published Erratum

No authors listed. JAMA Neurol. 2024.

. 2024 Feb 1;81(2):200.

doi: 10.1001/jamaneurol.2023.5238.

No abstract available

Erratum for

Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy: A Phase 2b Randomized Clinical Trial.
French JA, Porter RJ, Perucca E, Brodie MJ, Rogawski MA, Pimstone S, Aycardi E, Harden C, Qian J, Rosenblut CL, Kenney C, Beatch GN; X-TOLE Study Group. French JA, et al. JAMA Neurol. 2023 Nov 1;80(11):1145-1154. doi: 10.1001/jamaneurol.2023.3542. JAMA Neurol. 2023. PMID: 37812429 Free PMC article. Clinical Trial.

1. French JA, Porter RJ, Perucca E, et al. . Efficacy and safety of XEN1101, a novel potassium channel opener, in adults with focal epilepsy: a phase 2b randomized clinical trial. JAMA Neurol. 2023;80(11):1145-1154. doi:10.1001/jamaneurol.2023.3542 - DOI - PMC - PubMed